Evaluation of Concurrent Chemoradiotherapy for Survival Outcomes in Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma

IMPORTANCE: The optimal treatment for and potential benefit populations of synchronous oligometastatic esophageal squamous cell carcinoma (SOESCC) remain unclear. OBJECTIVES: To evaluate outcomes of concurrent chemoradiotherapy (CCRT) and to construct decision tree models for predicting the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Zhenguo, Zhu, Xiaojuan, Ruan, Changli, Wei, Gang, Li, Jiaojiao, Qiu, Hu, Gao, Lijuan, Cai, Gaoke, Zhangcai, Yutian, Li, Bin, Wang, Jing, Gong, Yi, Chen, Jiamei, Zhao, Wensi, Wu, Yong, Ke, Shaobo, Chen, Yongshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716398/
https://www.ncbi.nlm.nih.gov/pubmed/36454568
http://dx.doi.org/10.1001/jamanetworkopen.2022.44619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716398/
https://www.ncbi.nlm.nih.gov/pubmed/36454568
http://dx.doi.org/10.1001/jamanetworkopen.2022.44619

Ejemplares similares